Yali Friedman, Ph.D.
@jcommbiotech
Followers
3K
Following
1
Media
73
Statuses
7K
Journal of Commercial Biotechnology is a quarterly peer-reviewed journal focused on the business of biotechnology. Free sample papers at http://t.co/Jf2NAojbvd
Washington, DC
Joined March 2011
The Code Breaker: Jennifer Doudna, gene editing, and the future of the human race
0
1
1
Waiving COVID-19 Vaccine Patents: A Bad Idea and a Dangerous Precedent
0
2
3
A Note on Corporate Open Innovation: Engagement with Startups
0
2
0
Illumina Accelerator: Next-Gen Corporate Accelerator with a Customer-Creation Focus
0
2
1
Building technology enabled platform companies in Biopharma – a perspective on early-stage value creation from Millennium, Alnylam, Moderna, & Kymera
0
1
0
Abridge: A mission driven approach to machine learning for healthcare conversation
0
3
0
Value over Volume: Maximizing Resources by Prioritizing Value: The Dubai Healthcare Experience
0
1
0
Using Lean Startup to Discover Customers in the mHealth Industry: Current Landscape and Challenges
0
1
0
Bioentrepreneurship education: where have we been and where to next?
0
1
0
Vaccine Hesitancy: When Political Miscommunication Replaces Scientific Benefit/Risk Assessment
0
1
0
Platform technology management of biotechnology companies in Japan
0
1
0
CONSENSUS ON METRICS FOR THE ASSESSMENT OF A MEDICAL SCIENCE LIAISON USING THE DELPHI METHOD
0
1
0
A conversation on accelerating innovation in biopharma and life sciences through global collaboration and alliances
0
1
0
Considerations for Potential Global Expansion of Serum Institute of India
0
1
0
The Role of the Biotechnology Industry in Addressing Health Inequities in Africa: Strengthening the Entire Health Care Value Chain
0
1
0